KSB-102

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKSB-102
Drug Alias Nameanti-EGFr monoclonal antibodies (KS Biomedix)epidermal growth factor receptor MAb (KS Biomedix)KSB-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsHead and Neck NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKS Biomedix Holdings PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKS Biomedix Holdings PLC
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A